Context-Dependent Regulation of Type17 Immunity by Microbiota at the Intestinal Barrier

다국어 초록 (Multilingual Abstract)

T-helper-17 (Th17) cells and related IL-17-producing (type17) lymphocytes are abundant at the epithelial barrier. In response to bacterial and fungal infection, the signature cytokines IL-17A/F and IL-22 mediate the antimicrobial immune response and contribute to wound healing of injured tissues. Despite their protective function, type17 lymphocytes are also responsible for various chronic inflammatory disorders, including inflammatory bowel disease (IBD) and colitis associated cancer (CAC). A deeper understanding of type17 regulatory mechanisms could ultimately lead to the discovery of therapeutic strategies for the treatment of chronic inflammatory disorders and the prevention of cancer. In this review, we discuss the current understanding of the development and function of type17 immune cells at the intestinal barrier, focusing on the impact of microbiota-immune interactions on intestinal barrier homeostasis and disease etiology.

참고문헌 (Reference)

1 Neumann C, "c-Maf-dependent Treg cell control of intestinal TH17 cells and IgA establishes hostmicrobiota homeostasis" 20 : 471-481, 2019

2 Xu M, "c-MAFdependent regulatory T cells mediate immunological tolerance to a gut pathobiont" 554 : 373-377, 2018

3 Bigaeva E, "Understanding human gut diseases at singlecell resolution" 29 (29): R51-R58, 2020

4 Atarashi K, "Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota" 500 : 232-236, 2013

5 Cai Z, "Treatment of inflammatory bowel disease: a comprehensive review" 8 : 765474-, 2021

6 Rutz S, "Transcription factor c-Maf mediates the TGF-β-dependent suppression of IL-22 production in T(H)17cells" 12 : 1238-1245, 2011

7 Bilsborough J, "Therapeutic targets in inflammatory bowel disease : current and future" 3 : 27-37, 2016

8 Luu M, "The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolicepigenetic crosstalk in lymphocytes" 10 : 760-, 2019

9 Van Kaer L, "The response of CD1d-restricted invariant NKT cells to microbial pathogens and their products" 6 : 226-, 2015

10 Ohnmacht C, "The microbiota regulates type 2 immunity through RORγt+ T cells" 349 : 989-993, 2015

11 Honda K, "The microbiota in adaptive immune homeostasis and disease" 535 : 75-84, 2016

12 Glassner KL, "The microbiome and inflammatory bowel disease" 145 : 16-27, 2020

13 Omenetti S, "The intestine harbors functionally distinct homeostatic tissue-resident and inflammatory Th17 cells" 51 : 77-89, 2019

14 Gopalakrishnan V, "The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy" 33 : 570-580, 2018

15 Stockinger B, "The dichotomous nature of T helper 17 cells" 17 : 535-544, 2017

16 Chinen I, "The aryl hydrocarbon receptor/microRNA-212/132 axis in T cells regulates IL-10production to maintain intestinal homeostasis" 27 : 405-415, 2015

17 Ye J, "The aryl hydrocarbon receptor preferentially marks and promotes gut regulatory T cells" 21 : 2277-2290, 2017

18 Shinde R, "The aryl hydrocarbon receptor : Connecting immunity to the microenvironment" 39 : 1005-1020, 2018

19 Vaishnava S, "The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine" 334 : 255-258, 2011

20 Wang K, "The IL-23 to IL-17 cascade inflammation-related cancers" 33 (33): S87-S90, 2015

21 Gagliani N, "Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation" 523 : 221-225, 2015

22 Zhao J, "Th17 cells in inflammatory bowel disease : Cytokines, plasticity, and therapies" 2021 : 8816041-, 2021

23 Atarashi K, "Th17 cell induction by adhesion of microbes to intestinal epithelial cells" 163 : 367-380, 2015

24 Miossec P, "Targeting IL-17 and TH17 cells in chronic inflammation" 11 : 763-776, 2012

25 Kempski J, "TH17 cell and epithelial cell crosstalk during inflammatory bowel disease and carcinogenesis" 8 : 1373-, 2017

26 Leng T, "TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions" 28 : 3077-3091, 2019

27 Biton M, "T helper cell cytokines modulate intestinal stem cell renewal and differentiation" 175 : 1307-1320, 2018

28 Baxter NT, "Structure of the gut microbiome following colonization with human feces determines colonic tumor burden" 2 : 20-, 2014

29 Schnell A, "Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity" 184 : 6281-6298, 2021

30 Geem D, "Specific microbiotainduced intestinal Th17 differentiation requires MHC class II but not GALT and mesenteric lymph nodes" 193 : 431-438, 2014

31 Ivanov II, "Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine" 4 : 337-349, 2008

32 Gaublomme JT, "Single-cell genomics unveils critical regulators of Th17 cell pathogenicity" 163 : 1400-1412, 2015

33 Martin JC, "Single-cell analysis of Crohn’s disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy" 178 : 1493-1508, 2019

34 Jaeger N, "Single-cell analyses of Crohn’s disease tissues reveal intestinal intraepithelial T cells heterogeneity and altered subset distributions" 12 : 1921-, 2021

35 Lee JY, "Serum amyloid A proteins induce pathogenic Th17 cells and promote inflammatory disease" 180 : 79-91, 2020

36 Davis TA, "Serum amyloid A promotes inflammation-associated damage and tumorigenesis in a mouse model of colitis-associated cancer" 12 : 1329-1341, 2021

37 Bang YJ, "Serum amyloid A delivers retinol to intestinal myeloid cells to promote adaptive immunity" 373 : eabf9232-, 2021

38 Goto Y, "Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation" 40 : 594-607, 2014

39 Zhu C, "Roseburia intestinalis inhibits interleukin-17 excretion and promotes regulatory T cells differentiation in colitis" 17 : 7567-7574, 2018

40 Belkaid Y, "Role of the microbiota in immunity and inflammation" 157 : 121-141, 2014

41 Sun M, "Regulatory immune cells in regulation of intestinal inflammatory response to microbiota" 8 : 969-978, 2015

42 Kayama H, "Regulation of intestinal homeostasis by innate and adaptive immunity" 24 : 673-680, 2012

43 Brockmann L, "Regulation of TH17 cells and associated cytokines in wound healing, tissue regeneration, and carcinogenesis" 18 : E1033-, 2017

44 James KR, "Redefining intestinal immunity with single-cell transcriptomics" 15 : 531-541, 2022

45 Eckle SB, "Recognition of vitamin B precursors and byproducts by mucosal associated invariant T cells" 290 : 30204-30211, 2015

46 Maynard CL, "Reciprocal interactions of the intestinal microbiota and immune system" 489 : 231-241, 2012

47 Silber J, "Randomized, double-blind, placebo (PBO)-controlled, single- and multiple-dose phase 1 study of VE202, a defined bacterial consortium for treatment of IBD: safety and colonization dynamics of a novel live biotherapeutic product (LBP) in healthy adults" 28 (28): S65-S66, 2022

48 Sanos SL, "RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells" 10 : 83-91, 2009

49 Viljoen KS, "Quantitative profiling of colorectal cancerassociated bacteria reveals associations between fusobacterium spp., enterotoxigenic Bacteroides fragilis(ETBF)and clinicopathological features of colorectal cancer" 10 : e0119462-, 2015

50 Wang Z, "Protective role of fecal microbiota transplantation on colitis and colitis-associated colon cancer in mice is associated with Treg cells" 10 : 2498-, 2019

51 Lathrop SK, "Peripheral education of the immune system by colonic commensal microbiota" 478 : 250-254, 2011

52 Chow J, "Pathobionts of the gastrointestinal microbiota and inflammatory disease" 23 : 473-480, 2011

53 Veldhoen M, "Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells" 206 : 43-49, 2009

54 Selvanantham T, "NKT cell–deficient mice harbor an altered microbiota that fuels intestinal inflammation during chemically induced colitis" 197 : 4464-4472, 2016

55 Richard ML, "Mucosa-associated microbiota dysbiosis in colitis associated cancer" 9 : 131-142, 2018

56 Png CW, "Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria" 105 : 2420-2428, 2010

57 Targan SR, "Mo2083 a randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and efficacy of AMG 827 in subjects with moderate to severe Crohn’s disease" 143 : e26-, 2012

58 Britton GJ, "Microbiotas from humans with inflammatory bowel disease alter the balance of gut Th17 and RORγt+regulatory T cells and exacerbate colitis in mice" 50 : 212-224, 2019

59 Lehmann FM, "Microbiota-induced tissue signals regulate ILC3-mediated antigen presentation" 11 : 1794-, 2020

60 Martínez-López M, "Microbiota sensing by Mincle-Syk axis in dendritic cells regulates interleukin-17 and-22 production and promotes intestinal barrier integrity" 50 : 446-461, 2019

61 Diehl GE, "Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX(3)CR1(hi)cells" 494 : 116-120, 2013

62 Hacquard S, "Microbiota and host nutrition across plant and animal kingdoms" 17 : 603-616, 2015

63 Lynch JB, "Microbiomes as sources of emergent host phenotypes" 365 : 1405-1409, 2019

64 Kang M, "Microbiome and colorectal cancer : Unraveling host-microbiota interactions in colitisassociated colorectal cancer development" 32 : 3-13, 2017

65 Geuking MB, "Microbial modulation of intestinal T helper cell responses and implications for disease and therapy" 13 : 855-866, 2020

66 Satoh-Takayama N, "Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense" 29 : 958-970, 2008

67 Olszak T, "Microbial exposure during early life has persistent effects on natural killer T cell function" 336 : 489-493, 2012

68 Duan J, "Microbial colonization drives expansion of IL-1 receptor 1-expressing and IL-17-producing γ/δ T cells" 7 : 140-150, 2010

69 Song X, "Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis" 577 : 410-415, 2020

70 Chun E, "Metabolite-sensing receptor Ffar2 regulates colonic group 3 innate lymphoid cells and gut immunity" 51 : 871-884, 2019

71 Howson LJ, "MR1-restricted mucosal-associated invariant T cells and their activation during infectious diseases" 6 : 303-, 2015

72 HarriffMJ, "MR1 displays the microbial metabolome driving selective MR1-restricted T cell receptor usage" 3 : eaao2556-, 2018

73 Bland P, "MHC class II expression by the gut epithelium" 9 : 174-178, 1988

74 Koyama M, "MHC class II antigen presentation by the intestinal epithelium initiates graftversus-host disease and is influenced by the microbiota" 51 : 885-898, 2019

75 Nel I, "MAIT cells, guardians of skin and mucosa" 14 : 803-814, 2021

76 Amini A, "MAIT cells in barrier tissues : lessons from immediate neighbors" 11 : 584521-, 2020

77 Constantinides MG, "MAIT cells are imprinted by the microbiota in early life and promote tissue repair" 366 : eaax6624-, 2019

78 Hinks TS, "MAIT cell activation and functions" 11 : 1014-, 2020

79 Smillie CS, "Intra-and inter-cellular rewiring of the human colon during Ulcerative Colitis" 178 : 714-730, 2019

80 Panea C, "Intestinal monocyte-derived macrophages control commensal-specific Th17 responses" 12 : 1314-1324, 2015

81 Jamwal DR, "Intestinal epithelial expression of MHCII determines severity of chemical, T-cell–induced, and infectious colitis in mice" 159 : 1342-1356, 2020

82 Hoytema van Konijnenburg DP, "Intestinal epithelial and intraepithelial T cell crosstalk mediates a dynamic response to infection" 171 : 783-794, 2017

83 Kumar P, "Intestinal Interleukin-17 receptor signaling mediates reciprocal control of the gut microbiota and autoimmune inflammation" 44 : 659-671, 2016

84 Hue S, "Interleukin-23drives innate and T cell-mediated intestinal inflammation" 203 : 2473-2483, 2006

85 Ahern PP, "Interleukin-23 drives intestinal inflammation through direct activity on T cells" 33 : 279-288, 2010

86 Wang K, "Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis" 41 : 1052-1063, 2014

87 Zhang M, "Interactions between intestinal microbiota and host immune response in inflammatory bowel disease" 8 : 942-, 2017

88 Kayama H, "Interaction between the microbiota, epithelia, and immune cells in the intestine" 38 : 23-48, 2020

89 Zheng D, "Interaction between microbiota and immunity in health and disease" 30 : 492-506, 2020

90 Goto Y, "Innate lymphoid cells regulate intestinal epithelial cell glycosylation" 345 : 1254009-, 2014

91 Hepworth MR, "Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria" 498 : 113-117, 2013

92 Diefenbach A, "Innate lymphoid cell-epithelial cell modules sustain intestinal homeostasis" 52 : 452-463, 2020

93 Cahill RJ, "Inflammatory bowel disease : an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus" 65 : 3126-3131, 1997

94 Ivanov II, "Induction of intestinal Th17 cells by segmented filamentous bacteria" 139 : 485-498, 2009

95 Atarashi K, "Induction of colonic regulatory T cells by indigenous Clostridium species" 331 : 337-341, 2011

96 Lee Y, "Induction and molecular signature of pathogenic TH17 cells" 13 : 991-999, 2012

97 Sefik E, "Individual intestinal symbionts induce a distinct population of RORγ+ regulatory T cells" 349 : 993-997, 2015

98 Sag D, "Improved detection of cytokines produced by invariant NKT cells" 7 : 16607-, 2017

99 Hepworth MR, "Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4+ T cells" 348 : 1031-1035, 2015

100 Duerkop BA, "Immune responses to the microbiota at the intestinal mucosal surface" 31 : 368-376, 2009

101 Tan TG, "Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17cells in mice" 113 : E8141-E8150, 2016

102 Li G, "Identification of novel population-specific cell subsets in Chinese Ulcerative Colitis patients using single-cell RNA sequencing" 12 : 99-117, 2021

103 Quévrain E, "Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease" 65 : 415-425, 2016

104 Okada S, "IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations" 349 : 606-613, 2015

105 Kullberg MC, "IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis" 203 : 2485-2494, 2006

106 Lin X, "IL-17RA-signaling in Lgr5+ intestinal stem cells induces expression of transcription factor ATOH1 to promote secretory cell lineage commitment" 55 : 237-253, 2022

107 Chen YS, "IL-17-producing γδ T cells protect against Clostridium difficile infection" 130 : 2377-2390, 2020

108 Segura E, "Human inflammatory dendritic cells induce Th17 cell differentiation" 38 : 336-348, 2013

109 Patterson AM, "Human gut symbiont Roseburia hominis promotes and regulates innate immunity" 8 : 1166-, 2017

110 Ahn J, "Human gut microbiome and risk for colorectal cancer" 105 : 1907-1911, 2013

111 Caruso R, "Host-microbiota interactions in inflammatory bowel disease" 20 : 411-426, 2020

112 Belkaid Y, "Homeostatic immunity and the microbiota" 46 : 562-576, 2017

113 Nakamoto N, "Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis" 4 : 492-503, 2019

114 Dupraz L, "Gut microbiota-derived short-chain fatty acids regulate IL-17 production by mouse and human intestinal γδ T cells" 36 : 109332-, 2021

115 Agus A, "Gut microbiota regulation of tryptophan metabolism in health and disease" 23 : 716-724, 2018

116 Jarade A, "Group 3 innate lymphoid cells mediate host defense against attaching and effacing pathogens" 63 : 83-91, 2021

117 Kameyama H, "Genomic characterization of colitis-associated colorectal cancer" 16 : 121-, 2018

118 Ismail AS, "Gammadelta intraepithelial lymphocytes are essential mediators of host-microbial homeostasis at the intestinal mucosal surface" 108 : 8743-8748, 2011

119 Sonnenberg GF, "Functional interactions between innate lymphoid cells and adaptive immunity" 19 : 599-613, 2019

120 Melo-Gonzalez F, "Functional and phenotypic heterogeneity of group 3 innate lymphoid cells" 150 : 265-275, 2017

121 Yang Y, "Focused specificity of intestinal TH17 cells towards commensal bacterial antigens" 510 : 152-156, 2014

122 Talbot J, "Feeding-dependent VIP neuron-ILC3 circuit regulates the intestinal barrier" 579 : 575-580, 2020

123 Schiering C, "Feedback control of AHR signalling regulates intestinal immunity" 542 : 242-245, 2017

124 Zhou L, "Faecalibacterium prausnitzii produces butyrate to maintain Th17/Treg balance and to ameliorate colorectal colitis by inhibiting Histone Deacetylase 1" 24 : 1926-1940, 2018

125 Agerholm R, "Evolved to protect, designed to destroy : IL-17-producing γδ T cells in infection, inflammation, and cancer" 51 : 2164-2177, 2021

126 Stephens WZ, "Epithelial-myeloid exchange of MHC class II constrains immunity and microbiota composition" 37 : 109916-, 2021

127 Gattu S, "Epithelial retinoic acid receptor β regulates serum amyloid A expression and vitamin A-dependent intestinal immunity" 116 : 10911-10916, 2019

128 Balish E, "Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice" 160 : 2253-2257, 2002

129 Ladinsky MS, "Endocytosis of commensal antigens by intestinal epithelial cells regulates mucosal T cell homeostasis" 363 : eaat4042-, 2019

130 Sinha SR, "Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation" 27 : 659-670, 2020

131 Joossens M, "Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives" 60 : 631-637, 2011

132 Happel KI, "Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae" 202 : 761-769, 2005

133 Mar JS, "Disease severity and immune activity relate to distinct interkingdom gut microbiome states in ethnically distinct ulcerative colitis patients" 7 : e01072-16, 2016

134 Zamani S, "Detection of enterotoxigenic Bacteroides fragilis in patients with ulcerative colitis" 9 : 53-, 2017

135 Guilliams M, "Dendritic cells, monocytes and macrophages : a unified nomenclature based on ontogeny" 14 : 571-578, 2014

136 Gaudino SJ, "Cross-talk between antigen presenting cells and T cells impacts intestinal homeostasis, bacterial infections, and tumorigenesis" 10 : 360-, 2019

137 Kim CH, "Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids" 18 : 1161-1171, 2021

138 Ansaldo E, "Control of immunity by the microbiota" 39 : 449-479, 2021

139 Quintana FJ, "Control of T(reg)and T(H)17 cell differentiation by the aryl hydrocarbon receptor" 453 : 65-71, 2008

140 Kushwah R, "Complexity of dendritic cell subsets and their function in the host immune system" 133 : 409-419, 2011

141 Ning C, "Complement activation promotes colitis-associated carcinogenesis through activating intestinal IL-1β/IL-17A axis" 8 : 1275-1284, 2015

142 Furusawa Y, "Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells" 504 : 446-450, 2013

143 Ryan FJ, "Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease" 11 : 1512-, 2020

144 Puel A, "Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity" 332 : 65-68, 2011

145 Lo Presti E, "Characterization of γδT cells in intestinal mucosa from patients with early-onset or long-standing inflammatory bowel disease and their correlation with clinical status" 13 : 873-883, 2019

146 Hovhannisyan Z, "Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases" 140 : 957-965, 2011

147 Panaccione R, "Briakinumab for treatment of Crohn’s disease : results of a randomized trial" 21 : 1329-1340, 2015

148 Hang S, "Bile acid metabolites control TH17 and Treg cell differentiation" 576 : 143-148, 2019

149 Chung L, "Bacteroides fragilis toxin coordinates a pro-carcinogenic inflammatory cascade via targeting of colonic epithelial cells" 23 : 203-214, 2018

150 Shao X, "Bacteroides fragilis restricts colitis-associated cancer via negative regulation of the NLRP3 axis" 523 : 170-181, 2021

151 Melo-Gonzalez F, "Antigen-presenting ILC3 regulate T cell-dependent IgA responses to colonic mucosal bacteria" 216 : 728-742, 2019

152 Eberl M, "Antigen recognition by human γδ T cells : one step closer to knowing" 98 : 351-354, 2020

153 Kedmi R, "Antigen presentation by type 3 innate lymphoid cells instructs the differentiation of gut microbiotaspecific regulatory T cells"

154 Mazmanian SK, "An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system" 122 : 107-118, 2005

155 Sano T, "An IL-23R/IL-22 circuit regulates epithelial serum amyloid A to promote local effector Th17 responses" 163 : 381-393, 2015

156 Khan I, "Alteration of gut microbiota in inflammatory bowel disease(IBD) : Cause or consequence? IBD treatment targeting the gut microbiome" 8 : E126-, 2019

157 Xiong L, "Ahr-Foxp3-RORγt axis controls gut homing of CD4+ T cells by regulating GPR15" 5 : eaaz7277-, 2020

158 Repoila F, "Adaptation of the gut pathobiont Enterococcus faecalis to deoxycholate and taurocholate bile acids" 12 : 8485-, 2022

159 Sandborn WJ, "A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn’s disease" 135 : 1130-1141, 2008

160 Ito H, "A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn’s disease" 126 : 989-996, 2004

161 Henn MR, "A phase 1b safety study of SER-287, a spore-based microbiome therapeutic, for active mild to moderate ulcerative colitis" 160 : 115-127, 2021

162 Mazmanian SK, "A microbial symbiosis factor prevents intestinal inflammatory disease" 453 : 620-625, 2008

163 Coombes JL, "A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β and retinoic acid-dependent mechanism" 204 : 1757-1764, 2007

164 Devlin AS, "A biosynthetic pathway for a prominent class of microbiota-derived bile acids" 11 : 685-690, 2015

165 Li W, "A bacterial bile acid metabolite modulates Treg activity through the nuclear hormone receptor NR4A1" 29 : 1366-1377, 2021

166 Klose CS, "A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells" 494 : 261-265, 2013